Perceptive Advisors - Q1 2015 holdings

$1.29 Billion is the total value of Perceptive Advisors's 160 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 70.7% .

 Value Shares↓ Weighting
FOLD  AMICUS THERAPEUTICS INC$157,101,000
+30.8%
14,439,4440.0%12.21%
+21.2%
NBIX BuyNEUROCRINE BIOSCIENCES INC$148,566,000
+86.5%
3,741,267
+4.9%
11.54%
+72.9%
RTRX BuyRETROPHIN INC$66,728,000
+180.9%
2,784,980
+43.5%
5.19%
+160.3%
TSRO BuyTESARO INC$56,158,000
+70.9%
978,359
+10.8%
4.36%
+58.4%
RLYP BuyRELYPSA INC$52,451,000
+37.4%
1,454,142
+17.4%
4.08%
+27.3%
LBIO SellLION BIOTECHNOLOGIES INC$32,873,000
+29.9%
2,714,549
-15.6%
2.56%
+20.4%
XNCR BuyXENCOR INC$29,947,000
-3.1%
1,954,785
+1.4%
2.33%
-10.2%
DYAX SellDYAX CORP$29,774,000
+14.3%
1,777,000
-4.0%
2.31%
+6.0%
SRPT SellSAREPTA THERAPEUTICS INC$29,278,000
-28.1%
2,204,652
-21.6%
2.28%
-33.3%
NVRO BuyNEVRO CORP$26,700,000
+291.0%
557,056
+215.5%
2.08%
+262.1%
ACRX  ACELRX PHARMACEUTICALS INC$25,376,000
-42.6%
6,574,0600.0%1.97%
-46.8%
QURE BuyUNIQURE NV$25,227,000
+769.6%
1,039,332
+430.7%
1.96%
+706.6%
BLCM  BELLICUM PHARMACEUTICALS INC$24,245,000
+0.6%
1,046,4020.0%1.88%
-6.8%
VSAR BuyVERSARTIS INC$24,161,000
+22.4%
1,546,471
+66.1%
1.88%
+13.5%
ZBH BuyZIMMER HLDGS INC$21,247,000
+21.6%
180,793
+17.3%
1.65%
+12.6%
CEMP BuyCEMPRA INC$19,642,000
+237.5%
572,500
+131.3%
1.53%
+212.7%
RCPT SellRECEPTOS INC$19,588,000
-45.1%
118,794
-59.2%
1.52%
-49.2%
ACAD SellACADIA PHARMACEUTICALS INC$19,562,000
-43.6%
600,240
-45.1%
1.52%
-47.8%
ANIP SellANI PHARMACEUTICALS INC$19,252,000
+9.2%
307,784
-1.5%
1.50%
+1.2%
OTIC BuyOTONOMY INC$16,986,000
+12.2%
480,387
+5.7%
1.32%
+3.9%
BLUE SellBLUEBIRD BIO INC$16,304,000
-21.0%
135,000
-40.0%
1.27%
-26.8%
CSU BuyCAPITAL SR LIVING CORP$15,694,000
+152.0%
605,000
+142.0%
1.22%
+133.7%
B108PS BuyACTAVIS PLC$14,638,000
+276.9%
49,185
+226.0%
1.14%
+249.1%
PFNX BuyPFENEX INC$13,811,000
+366.3%
866,423
+114.1%
1.07%
+332.7%
PTLA BuyPORTOLA PHARMACEUTICALS INC$13,476,000
+1803.4%
355,000
+1320.0%
1.05%
+1674.6%
XLRN BuyACCELERON PHARMA INC$12,790,000
+3.4%
336,036
+5.8%
0.99%
-4.2%
THOR SellTHORATEC CORP$12,567,000
-1.4%
300,000
-23.6%
0.98%
-8.5%
SGMO  SANGAMO BIOSCIENCES INC$12,544,000
+3.1%
800,0000.0%0.98%
-4.4%
INSM SellINSMED INC$12,185,000
+14.8%
585,812
-14.6%
0.95%
+6.4%
NEPT  NEPTUNE TECHNOLOGIES BIORESO$10,935,000
-14.7%
6,750,4440.0%0.85%
-21.0%
QTNT BuyQUOTIENT LTD$10,702,000
+31.0%
550,870
+21.4%
0.83%
+21.5%
AEGR NewAEGERION PHARMACEUTICALS INC$9,973,000381,100
+100.0%
0.78%
SRPT BuySarepta Therapeutics Inccall$9,960,000
+52.9%
750,000
+66.7%
0.77%
+41.8%
ELGX BuyENDOLOGIX INC$9,645,000
+200.4%
565,000
+169.0%
0.75%
+178.8%
CLDN NewCELADON GROUP INCcall$8,987,000474,500
+100.0%
0.70%
 ANI PHARMACEUTICALS INCnote 3.000%12/0$8,621,000
+9.3%
7,500,0000.0%0.67%
+1.4%
ZSPH NewZS PHARMA INC$7,860,000186,777
+100.0%
0.61%
BIIB NewBIOGEN INC$7,685,00018,200
+100.0%
0.60%
SHPG BuySHIRE PLCsponsored adr$7,179,000
+237.8%
30,000
+200.0%
0.56%
+213.5%
ANTH BuyANTHERA PHARMACEUTICALS INC$7,166,000
+801.4%
1,603,156
+218.6%
0.56%
+731.3%
VBIV NewVBI VACCINES INC.$6,786,0002,610,356
+100.0%
0.53%
DYAX NewDYAX CORPput$6,702,000400,000
+100.0%
0.52%
CBPO SellCHINA BIOLOGIC PRODS INC$6,686,000
+34.3%
70,000
-5.4%
0.52%
+24.7%
NewSUPERNUS PHARMACEUTICALSinc note 7.500%$6,650,0002,915,000
+100.0%
0.52%
AGTC  APPLIED GENETIC TECHNOL CO$6,021,000
-4.9%
301,2220.0%0.47%
-11.9%
 ALLIQUA BIOMEDIC$5,834,000
-1.9%
1,121,9510.0%0.45%
-9.2%
ASMB NewASSEMBLY BIOSCIENCES INC$5,627,000425,000
+100.0%
0.44%
TKAI SellTOKAI PHARMACEUTICALS INC$5,484,000
-23.3%
458,338
-5.6%
0.43%
-29.0%
CPRX NewCATALYST PHARM PARTNERS INC$5,196,0001,200,000
+100.0%
0.40%
MDGN BuyMEDGENICS INC$5,146,000
+97.8%
639,225
+24.3%
0.40%
+83.5%
FPRX BuyFIVE PRIME THERAPEUTICS IN$5,121,000
+22.2%
224,129
+44.4%
0.40%
+13.1%
AFMD SellAFFIMED N V$5,076,000
-18.6%
805,820
-19.9%
0.39%
-24.7%
TARO SellTARO PHARMACEUTICAL INDS LTD$4,736,000
-79.3%
33,574
-78.2%
0.37%
-80.8%
 NEURODERM LTD$4,697,000
-4.4%
350,0000.0%0.36%
-11.4%
LJPC SellLA JOLLA PHARMACEUTICAL CO$4,628,000
-13.2%
252,915
-12.5%
0.36%
-19.5%
ALDR NewALDER BIOPHARMACEUTICALS INC$4,329,000150,000
+100.0%
0.34%
THOR  THORATEC CORPcall$4,189,000
+29.1%
100,0000.0%0.33%
+19.9%
ARDX BuyARDELYX INC$4,136,000
-14.4%
315,955
+23.6%
0.32%
-20.7%
NERV NewMINERVA NEUROSCIENCES$4,052,000810,537
+100.0%
0.32%
PTBI  PLASMATECH BIOPHARMACEUTICAL$3,925,000
-10.3%
1,250,0000.0%0.30%
-16.9%
TRXC SellTRANSENTERIX INC$3,893,000
-36.2%
1,328,668
-36.6%
0.30%
-40.7%
XENE  XENON PHARMACEUTICALS INC$3,795,000
-14.6%
225,0000.0%0.30%
-20.9%
HCA BuyHCA HOLDINGS INC$3,762,000
+5.4%
50,000
+2.8%
0.29%
-2.3%
TTPH  TETRAPHASE PHARMACEUTICALS I$3,664,000
-7.7%
100,0000.0%0.28%
-14.4%
ALDX NewALDEYRA THERAPEUTICS$3,634,000357,000
+100.0%
0.28%
SAGE  SAGE THERAPEUTICS INC$3,540,000
+37.2%
70,4840.0%0.28%
+27.3%
CELG SellCELGENE CORP$3,455,000
-78.9%
29,967
-79.6%
0.27%
-80.5%
MGNX SellMACROGENICS INC$3,332,000
-56.0%
106,208
-50.8%
0.26%
-59.2%
PRTO  PROTEON THERAPEUTICS INC$3,198,000
+11.8%
275,0000.0%0.25%
+3.8%
CSBR BuyCHAMPIONS ONCOLOGY$3,082,000
+279.6%
4,403,680
+170.9%
0.24%
+252.9%
PCYC NewPHARMACYCLICS INC$3,071,00012,000
+100.0%
0.24%
RDUS NewRADIUS HEALTH INC$3,046,00074,000
+100.0%
0.24%
RGEN  REPLIGEN CORPput$3,036,000
+53.3%
100,0000.0%0.24%
+42.2%
DSCI BuyDERMA SCIENCES INC$2,908,000
-0.4%
343,284
+9.5%
0.23%
-7.8%
RPTP NewRAPTOR PHARMACEUTICAL CORP$2,872,000264,200
+100.0%
0.22%
NVTA NewINVITAE CORP$2,765,000165,000
+100.0%
0.22%
IMMU NewIMMUNOMEDICS INCput$2,625,000600,000
+100.0%
0.20%
CHRS SellCOHERUS BIOSCIENCES INC$2,608,000
-63.5%
85,288
-80.5%
0.20%
-66.1%
MGCD  MGC DIAGNOSTICS CORP$2,475,000
+15.0%
336,2870.0%0.19%
+6.7%
HEWG NewISHARES TRhdg msci germn$2,426,00085,000
+100.0%
0.19%
DERM  DERMIRA INC$2,333,000
-15.3%
152,0000.0%0.18%
-21.6%
VCEL SellVERICEL CORP$2,180,000
-15.6%
589,297
-30.7%
0.17%
-22.1%
CLDN NewCELADON GROUP INCput$1,894,000100,000
+100.0%
0.15%
GNVC SellGENVEC INC$1,811,000
-18.6%
615,844
-40.8%
0.14%
-24.6%
BCLI NewBRAINSTORM CELL THERAPEUTICS$1,780,000400,000
+100.0%
0.14%
DRRX  DURECT CORP$1,732,000
+141.9%
907,0640.0%0.14%
+125.0%
WBA  WALGREENS BOOTS ALLIANCE INC$1,719,000
+11.2%
20,2920.0%0.13%
+3.1%
SNSS BuySUNESIS PHARMACEUTICALS INC$1,715,000
+34.5%
700,000
+40.0%
0.13%
+24.3%
ONTY BuyONCOTHYREON INC$1,508,000
+144.0%
925,000
+184.6%
0.12%
+125.0%
TCON NewTRACON PHARMACEUTICALS INC$1,404,000100,000
+100.0%
0.11%
PSDV  PSIVIDA CORP$1,244,000
-3.9%
315,0000.0%0.10%
-11.0%
AVGR NewAVINGER INC$1,248,000112,500
+100.0%
0.10%
UPI BuyUROPLASTY INC$1,179,000
-25.3%
966,349
+26.1%
0.09%
-30.3%
NewARNO THERAPEUTICS INC$1,179,0002,034,721
+100.0%
0.09%
PTBIW  PLASMATECH BIOPHARMACEUTICAL*w exp 10/24/201$1,163,000
+16.3%
1,250,0000.0%0.09%
+7.1%
ONCE NewSPARK THERAPEUTICS INC$1,163,00015,000
+100.0%
0.09%
ALIM SellALIMERA SCIENCES INC$1,161,000
-45.1%
231,900
-39.3%
0.09%
-49.2%
STML NewSTEMLINE THERAPEUTICS INC$1,147,00079,245
+100.0%
0.09%
ACST SellACASTI PHARMA INC$1,134,000
-11.8%
2,365,600
-8.1%
0.09%
-18.5%
AQXP  AQUINOX PHARMACEUTICALS IN$1,115,000
+14.4%
130,0000.0%0.09%
+6.1%
KERX NewKERYX BIOPHARMACEUTICALS INC$1,074,00084,380
+100.0%
0.08%
GILD NewGILEAD SCIENCES INC$981,00010,000
+100.0%
0.08%
PARNF SellPARNELL PHARMACEUT HLDGS$964,000
+8.6%
196,500
-8.2%
0.08%
+1.4%
AGEN SellAGENUS INC$929,000
-41.9%
181,117
-55.0%
0.07%
-46.3%
VNDA  VANDA PHARMACEUTICALS INCput$930,000
-35.1%
100,0000.0%0.07%
-40.0%
VNDA SellVANDA PHARMACEUTICALS INCcall$930,000
-89.2%
100,000
-83.3%
0.07%
-90.0%
INCY NewINCYTE CORP$917,00010,000
+100.0%
0.07%
INFI BuyINFINITY PHARMACEUTICALS INC$853,000
+229.3%
61,000
+298.1%
0.07%
+200.0%
ABMD NewABIOMED INC$716,00010,000
+100.0%
0.06%
GLMD  GALMED PHARMACEUTICALS LTD$706,000
+62.3%
75,0000.0%0.06%
+52.8%
IMPR NewIMPRIVATA INC$700,00050,000
+100.0%
0.05%
ASPX NewAUSPEX PHARMACEUTICALS INC$602,0006,000
+100.0%
0.05%
AKAOQ  ACHAOGEN INC$586,000
-25.2%
60,0000.0%0.05%
-30.3%
ILMN NewILLUMINA INC$531,0002,859
+100.0%
0.04%
EGRX NewEAGLE PHARMACEUTICALS INC$506,00012,088
+100.0%
0.04%
BVX NewBOVIE MEDICAL CORP$478,000200,000
+100.0%
0.04%
THC SellTENET HEALTHCARE CORP$449,000
-88.3%
8,500
-88.8%
0.04%
-89.2%
MDT NewMEDTRONIC PLC$390,0005,000
+100.0%
0.03%
MRGE  MERGE HEALTHCARE INC$368,000
+25.6%
82,4270.0%0.03%
+16.0%
ARIA NewARIAD PHARMACEUTICALS INC$346,00041,949
+100.0%
0.03%
HPTX NewHYPERION THERAPEUTICS INC$317,0006,913
+100.0%
0.02%
MYL NewMYLAN N V$305,0005,133
+100.0%
0.02%
LCI  LANNET INC$297,000
+58.0%
4,3920.0%0.02%
+43.8%
CBM SellCAMBREX CORP$291,000
+17.3%
7,331
-36.2%
0.02%
+9.5%
AET  AETNA INC NEW$275,000
+19.6%
2,5860.0%0.02%
+10.5%
GB NewGREATBATCH INC$254,0004,391
+100.0%
0.02%
UTHR NewUNITED THERAPEUTICS CORP DEL$255,0001,481
+100.0%
0.02%
UHS  UNIVERSAL HLTH SVCS INCcl b$263,000
+6.0%
2,2330.0%0.02%
-4.8%
CI SellCIGNA CORPORATION$255,000
+11.8%
1,970
-11.2%
0.02%
+5.3%
WCG NewWELLCARE HEALTH PLANS INC$246,0002,690
+100.0%
0.02%
HNT SellHEALTH NET INC$249,000
-7.4%
4,109
-18.2%
0.02%
-17.4%
SCAI SellSURGICAL CARE AFFILIATES$241,000
-6.9%
7,020
-8.9%
0.02%
-13.6%
LH NewLABORATORY CORP AMER HLDGS$247,0001,956
+100.0%
0.02%
PAHC SellPHIBRO ANIMAL HEALTH CORP$241,000
+1.7%
6,809
-9.5%
0.02%
-5.0%
CAH NewCARDINAL HEALTH INC$232,0002,574
+100.0%
0.02%
MCK NewMCKESSON CORP$230,0001,015
+100.0%
0.02%
RAD SellRITE AID CORP$218,000
-31.4%
25,063
-40.9%
0.02%
-37.0%
LPNT NewLIFEPOINT HOSPITALS INC$222,0003,025
+100.0%
0.02%
RDNT NewRADNET INC$223,00026,525
+100.0%
0.02%
ICLR NewICON PLC$204,0002,898
+100.0%
0.02%
EXAC SellEXACTECH INC$203,000
-17.1%
7,905
-23.8%
0.02%
-23.8%
CTLT NewCATALENT INC$200,0006,429
+100.0%
0.02%
GTS  TRIPLE-S MGMT CORPcl b$211,000
-16.9%
10,6050.0%0.02%
-23.8%
MGLN NewMAGELLAN HEALTH INC$205,0002,900
+100.0%
0.02%
CYTK NewCYTOKINETICS INC$205,00030,227
+100.0%
0.02%
AMSG NewAMSURG CORP$205,0003,328
+100.0%
0.02%
BKD NewBROOKDALE SR LIVING INC$189,0005,000
+100.0%
0.02%
LHCG SellLHC GROUP INC$195,000
-35.4%
5,917
-38.9%
0.02%
-40.0%
OXGN  OXIGENE INC$180,000
-9.5%
123,5180.0%0.01%
-17.6%
ASND NewASCENDIS PHARMA A Ssponsored adr$174,00010,000
+100.0%
0.01%
SURG NewSYNERGETICS USA INC$117,00021,786
+100.0%
0.01%
CLLS NewCELLECTIS S Asponsored ads$52,0001,500
+100.0%
0.00%
CAPR NewCAPRICOR THERAPEUTICS INC$35,0004,000
+100.0%
0.00%
ESPR SellESPERION THERAPEUTICS INC NE$9,000
-99.9%
102
-100.0%
0.00%
-99.9%
ICEL  CELLULAR DYNAMICS INTL INC$3,000
+200.0%
1640.0%0.00%
MNKD NewMANNKIND CORPcall$1,000100
+100.0%
0.00%
DBVT SellDBV TECHNOLOGIES S Asponsored adr$0
-100.0%
2
-100.0%
0.00%
-100.0%
TBIO SellTRANSGENOMIC INC$1,000
-99.6%
357
-99.7%
0.00%
-100.0%
XOMA ExitXOMA LTDcall$0-200
-100.0%
0.00%
SGEN ExitSEATTLE GENETICS INC /WAcall$0-900
-100.0%
-0.00%
OHRP ExitOHR PHARMACEUTICAL INC$0-6,000
-100.0%
-0.00%
SEM ExitSELECT MED HLDGS CORP$0-13,365
-100.0%
-0.02%
SUPN ExitSUPERNUS PHARMACEUTICALS INC$0-22,285
-100.0%
-0.02%
USPH ExitU S PHYSICAL THERAPY INC$0-5,156
-100.0%
-0.02%
PRXL ExitPAREXEL INTL CORP$0-4,005
-100.0%
-0.02%
BCR ExitBARD C R INC$0-1,367
-100.0%
-0.02%
CIVI ExitCIVITAS SOLUTIONS INC$0-13,585
-100.0%
-0.02%
PDLI ExitPDL BIOPHARMA INC$0-30,151
-100.0%
-0.02%
BSTC ExitBIOSPECIFICS TECHNOLOGIES CO$0-6,065
-100.0%
-0.02%
CYBX ExitCYBERONICS INC$0-4,454
-100.0%
-0.02%
SKH ExitSKILLED HEALTHCARE GROUP INCcl a$0-31,293
-100.0%
-0.02%
CNC ExitCENTENE CORP DEL$0-2,484
-100.0%
-0.02%
SCLN ExitSCICLONE PHARMACEUTICALS INC$0-29,942
-100.0%
-0.02%
NSPH ExitNANOSPHERE INC$0-707,566
-100.0%
-0.02%
CLVS ExitCLOVIS ONCOLOGY INC$0-5,138
-100.0%
-0.02%
GALE ExitGALENA BIOPHARMA INCput$0-200,000
-100.0%
-0.02%
THLD ExitTHRESHOLD PHARMACEUTICAL INC$0-160,000
-100.0%
-0.04%
SPNC ExitSPECTRANETICS CORP$0-16,335
-100.0%
-0.05%
SIEN ExitSIENTRA INC$0-37,000
-100.0%
-0.05%
HIIQ ExitHEALTH INS INNOVATIONS INC$0-96,000
-100.0%
-0.06%
MNKD ExitMANNKIND CORPput$0-200,000
-100.0%
-0.09%
ACHN ExitACHILLION PHARMACEUTICALS IN$0-106,100
-100.0%
-0.11%
ELOS ExitSYNERON MEDICAL LTD$0-152,609
-100.0%
-0.12%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-100,000
-100.0%
-0.15%
ABMD ExitABIOMED INCcall$0-50,000
-100.0%
-0.16%
PRQR ExitPROQR THRAPEUTICS N V$0-100,000
-100.0%
-0.18%
SNN ExitSMITH & NEPHEW PLCspdn adr new$0-67,407
-100.0%
-0.21%
JUNO ExitJUNO THERAPEUTICS INC$0-50,000
-100.0%
-0.22%
ARNI ExitARNO THERAPEUTICS, INC$0-2,034,721
-100.0%
-0.23%
KERX ExitKERYX BIOPHARMACEUTICALSput$0-200,000
-100.0%
-0.24%
VBLX ExitVASCULAR BIOGENICS LTD$0-500,000
-100.0%
-0.25%
FLML ExitFLAMEL TECHNOLOGIES SAsponsored adr$0-644,111
-100.0%
-0.31%
ALR ExitALERE INC$0-98,000
-100.0%
-0.31%
QDEL ExitQUIDEL CORP$0-142,500
-100.0%
-0.35%
MYL ExitMYLAN INC$0-76,210
-100.0%
-0.36%
PRTA ExitPROTHENA CORP PLC$0-247,336
-100.0%
-0.43%
HRTX ExitHERON THERAPEUTICS INC$0-666,042
-100.0%
-0.56%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-605,407
-100.0%
-0.61%
EPZM ExitEPIZYME INC$0-432,619
-100.0%
-0.68%
ZFGN ExitZAFGEN INC$0-278,313
-100.0%
-0.72%
BDX ExitBECTON DICKINSON & CO$0-80,000
-100.0%
-0.93%
VRTX ExitVERTEX PHARMACEUTICALS INCput$0-100,000
-100.0%
-1.00%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-110,000
-100.0%
-1.10%
AGN ExitALLERGAN INC$0-82,583
-100.0%
-1.47%
OPHT ExitOPHTHOTECH CORP$0-429,386
-100.0%
-1.62%
PTCT ExitPTC THERAPEUTICS INC$0-671,736
-100.0%
-2.92%
NBIX ExitNEUROCRINE BIOSCIENCES INCput$0-1,600,000
-100.0%
-3.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
Signatures

The EDGAR filing(s) were signed by:

About Perceptive Advisors

Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.

The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.

One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.

Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEUROCRINE BIOSCIENCES SHARES42Q3 202315.7%
AMICUS THERAPEUTICS SHARES39Q3 202314.0%
ALDEYRA THERAPEUTICS SHARES35Q3 20233.3%
QUOTIENT TECHNOLOGY INC34Q3 20222.7%
GLOBAL BLOOD THERAPEUTICS SHARES29Q3 20229.3%
ADMA BIOLOGICS SHARES29Q3 20231.4%
RETROPHIN SHARES28Q3 20205.5%
DBV TECHNOLOGIES SA-SPON ADR28Q3 20211.8%
VBI VACCINES SHARES27Q1 20232.8%
IOVANCE BIOTHERAPEUTICS INC26Q3 20239.1%

View Perceptive Advisors's complete holdings history.

Latest significant ownerships (13-D/G)
Perceptive Advisors Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CHEMBIO DIAGNOSTICS, INC.Sold outMay 04, 202300.0%
VBI Vaccines Inc/BCApril 07, 202343,509,55316.7%
Landos Biopharma, Inc.March 30, 202314,869,91547.7%
REATA PHARMACEUTICALS INCMarch 07, 20232,083,7996.5%
AGILE THERAPEUTICS INCSold outFebruary 14, 202300.0%
ALBIREO PHARMA, INC.February 14, 20231,757,1608.5%
BELLUS Health Inc.February 14, 20238,891,0277.1%
CinCor Pharma, Inc.February 14, 20232,576,3255.9%
Coherus BioSciences, Inc.Sold outFebruary 14, 202300.0%
CONCERT PHARMACEUTICALS, INC.February 14, 20231,800,0003.6%

View Perceptive Advisors's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D2024-03-20
SC 13G2024-03-14
SC 13G2024-03-11
SC 13G/A2024-03-06
SC 13D/A2024-03-01
SC 13G2024-03-01
SC 13D/A2024-02-29
13F-HR/A2024-02-26
SC 13G/A2024-02-23
42024-02-21

View Perceptive Advisors's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1290797000.0 != 1286807000.0)
  • The reported number of holdings is incorrect (160 != 158)

Export Perceptive Advisors's holdings